Novo shares fall 7.7 percent after new strategy launch
Danish pharma giant Novo saw its stock drop after investors questioned its new long-term growth plan.
2026年9月22日
/ DANGDI / DANGDI / DANGDI /Novo shares dropped 7.7 percent on Monday.
The drop followed a new strategy announcement in London.
As Denmark's biggest firm, its stock impacts local pension funds.
Novo was formerly known as Novo Nordisk.
The pharmaceutical giant announced a strategy update at an event.
It plans to diversify its drug offerings.
The new focus includes liver and heart diseases.
Novo aims to develop five blockbuster products before 2030.
Each product must net over one billion dollars annually.
The firm targets new product sales by 2035.
It wants over 150 billion Danish kroner in yearly sales from them.
Investors speaking to Danish newspaper Børsen criticized the plan.
They said the strategy lacked concrete goals.
They also worry about growth in the weight loss market.
Novo shares fell to their lowest level since April.
Philip Jagd is the head of shares at Sampension pension fund.
He noted that sales forecasts have worsened in recent years.
He said Novo must show it can grow with the industry.
Source: The Local Denmark
